bf/NYSE:ABBV_icon.jpeg

NYSE:ABBV

AbbVie Inc.

  • Stock

USD

Last Close

182.17

26/07 20:00

Market Cap

296.91B

Beta: 0.55

Volume Today

5.35M

Avg: 6.07M

PE Ratio

46.58

PFCF: 12.27

Dividend Yield

3.48%

Payout:159.95%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
18.79B
-
19.96B
6.23%
22.86B
14.52%
25.64B
12.16%
28.22B
10.06%
32.75B
16.08%
33.27B
1.57%
45.80B
37.69%
56.20B
22.69%
58.05B
3.30%
54.32B
6.44%
cost of revenue
4.58B
-
4.43B
3.38%
4.50B
1.67%
5.83B
29.62%
7.04B
20.69%
7.72B
9.63%
7.44B
3.61%
15.39B
106.84%
17.45B
13.38%
17.41B
0.18%
8.78B
49.58%
gross profit
14.21B
-
15.53B
9.33%
18.36B
18.19%
19.80B
7.88%
21.18B
6.92%
25.04B
18.22%
25.83B
3.16%
30.42B
17.77%
38.75B
27.40%
40.64B
4.87%
45.54B
12.05%
selling and marketing expenses
1.10B
-
1.80B
63.64%
2.10B
16.67%
2B
4.76%
general and administrative expenses
5.35B
-
7.72B
44.32%
6.39B
17.31%
5.86B
8.33%
6.28B
7.17%
7.40B
17.91%
5.84B
21.04%
9.50B
62.60%
10.25B
7.90%
13.26B
29.38%
selling general and administrative expenses
5.35B
-
7.72B
44.32%
6.39B
17.31%
5.86B
8.33%
6.28B
7.17%
7.40B
17.91%
6.94B
6.18%
11.30B
62.76%
12.35B
9.29%
15.26B
23.57%
13.14B
13.86%
research and development expenses
2.85B
-
3.30B
15.48%
4.29B
29.97%
4.37B
1.89%
4.98B
14.11%
10.33B
107.33%
6.41B
37.97%
6.56B
2.34%
7.08B
8.04%
6.51B
8.10%
7.03B
8.02%
other expenses
1M
-
27M
2,600%
-13M
148.15%
-232M
1,684.62%
-513M
121.12%
-18M
96.49%
-890M
4,844.44%
-5.61B
530.79%
432M
107.70%
56M
87.04%
-7.94B
14,271.43%
cost and expenses
12.79B
-
16.20B
26.66%
15.17B
6.33%
16.05B
5.81%
18.30B
13.97%
25.95B
41.80%
19.90B
23.31%
33.24B
67.07%
37.31B
12.24%
39.24B
5.17%
36.89B
5.98%
operating expenses
8.21B
-
11.77B
43.43%
10.67B
9.34%
10.22B
4.23%
11.26B
10.14%
18.23B
61.93%
12.46B
31.65%
17.86B
43.32%
19.86B
11.25%
21.83B
9.87%
28.11B
28.81%
interest expense
278M
-
391M
40.65%
686M
75.45%
965M
40.67%
1.00B
4.04%
1.14B
13.94%
1.51B
31.91%
2.28B
51.09%
2.38B
4.56%
2.23B
6.46%
1.67B
25.16%
ebitda
6.56B
-
4.20B
36.03%
8.37B
99.50%
10.57B
26.27%
11.09B
4.92%
8.15B
26.55%
13.79B
69.31%
6.95B
49.64%
26.45B
280.67%
26.58B
0.53%
18.10B
31.93%
operating income
5.66B
-
3.41B
39.78%
7.54B
120.96%
9.38B
24.51%
9.59B
2.22%
6.38B
33.45%
12.98B
103.40%
476M
96.33%
17.92B
3,665.55%
18.12B
1.08%
17.43B
3.82%
depreciation and amortization
897M
-
786M
12.37%
836M
6.36%
1.19B
42.22%
1.50B
26.24%
1.76B
17.59%
812M
53.99%
6.47B
696.92%
8.52B
31.68%
8.47B
0.63%
8.70B
2.73%
total other income expenses net
-392M
-
-1.00B
155.87%
-356M
64.51%
-735M
106.46%
-1.19B
61.63%
-466M
60.77%
-4.56B
877.90%
2.92B
164.12%
-3.51B
220.23%
-3.29B
6.26%
-11.18B
239.36%
income before tax
5.33B
-
2.37B
55.57%
6.64B
180.50%
7.88B
18.65%
7.73B
1.99%
5.20B
32.74%
8.43B
62.13%
3.40B
59.67%
12.99B
282.25%
13.48B
3.76%
6.25B
53.62%
income tax expense
1.20B
-
595M
50.58%
1.50B
152.27%
1.93B
28.65%
2.42B
25.22%
-490M
120.26%
544M
211.02%
-1.22B
325%
1.44B
217.65%
1.63B
13.33%
1.38B
15.63%
net income
4.13B
-
1.77B
57.03%
5.14B
189.97%
5.95B
15.73%
5.31B
10.82%
5.69B
7.12%
7.88B
38.60%
4.62B
41.44%
11.54B
150.04%
11.84B
2.55%
4.86B
58.91%
weighted average shs out
1.59B
-
1.59B
0.38%
1.63B
1.88%
1.62B
0.18%
1.60B
1.60%
1.54B
3.45%
1.48B
3.89%
1.67B
12.56%
1.77B
6.18%
1.77B
0.06%
1.77B
0.17%
weighted average shs out dil
1.60B
-
1.61B
0.37%
1.64B
1.68%
1.63B
0.37%
1.60B
1.72%
1.55B
3.56%
1.48B
4.01%
1.67B
12.74%
1.78B
6.22%
1.78B
0.06%
1.77B
0.28%
eps
2.58
-
1.11
56.98%
3.15
183.78%
3.65
15.87%
3.31
9.32%
3.69
11.48%
5.30
43.63%
2.73
48.49%
6.48
137.36%
6.65
2.62%
2.73
58.95%
epsdiluted
2.56
-
1.10
57.03%
3.13
184.55%
3.63
15.97%
3.30
9.09%
3.68
11.52%
5.28
43.48%
2.72
48.48%
6.45
137.13%
6.63
2.79%
2.72
58.97%

All numbers in USD (except ratios and percentages)